$444 Million is the total value of BRIDGER MANAGEMENT, LLC's 43 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PSPCU | POST HOLDINGS PARTNERING CORunit 99/99/9999 | $12,213,000 | -1.3% | 1,250,000 | 0.0% | 2.75% | +35.6% | |
| TEVA | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $11,280,000 | -19.9% | 1,500,000 | 0.0% | 2.54% | +10.1% | |
| AVANU | AVANTI ACQUISITION CORPunit 99/99/9999 | $10,000,000 | +0.3% | 1,000,000 | 0.0% | 2.25% | +37.9% | |
| AIRSCULPT TECHNOLOGIES INC | $9,695,000 | -56.7% | 1,634,941 | 0.0% | 2.18% | -40.4% | ||
| WILLIAMS ROWLAND ACQUISITION | $9,500,000 | +0.3% | 950,000 | 0.0% | 2.14% | +37.9% | ||
| FLME | FLAME ACQUISITION CORP | $4,895,000 | +0.4% | 500,000 | 0.0% | 1.10% | +37.9% | |
| BELLRING BRANDS INC | $4,657,000 | +7.8% | 187,122 | 0.0% | 1.05% | +48.3% | ||
| MSOS | ADVISORSHARES TRpure us cannabis | $2,216,000 | -50.4% | 214,100 | 0.0% | 0.50% | -31.7% | |
| SURROZEN INCcl a | $2,100,000 | -0.3% | 700,001 | 0.0% | 0.47% | +36.7% | ||
| ABCM | ABCAM PLCads | $2,058,000 | -21.0% | 142,350 | 0.0% | 0.46% | +8.7% | |
| NAUT | NAUTILUS BIOTECHNOLOGY INC | $777,000 | -38.0% | 289,000 | 0.0% | 0.18% | -15.0% | |
| NEXI | NEXIMMUNE INC | $644,000 | -61.8% | 400,000 | 0.0% | 0.14% | -47.5% | |
| SURROZEN INC*w exp 08/01/203 | $89,000 | -23.9% | 466,666 | 0.0% | 0.02% | +5.3% | ||
| WILLIAMS ROWLAND ACQUISITION*w exp 12/11/202 | $40,000 | -67.7% | 475,000 | 0.0% | 0.01% | -55.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERISIGN INC | 40 | Q1 2023 | 5.2% |
| TEVA PHARMACEUTICAL INDS LTD | 40 | Q3 2023 | 7.3% |
| MORGAN STANLEY | 35 | Q3 2023 | 11.8% |
| ALNYLAM PHARMACEUTICALS INC | 34 | Q3 2021 | 4.9% |
| POST HLDGS INC | 33 | Q4 2022 | 6.1% |
| TG THERAPEUTICS INC | 33 | Q3 2021 | 3.8% |
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 7.2% |
| ATARA BIOTHERAPEUTICS INC | 29 | Q4 2021 | 6.4% |
| GODADDY INC | 28 | Q3 2023 | 8.9% |
| CENTENE CORP DEL | 28 | Q3 2022 | 6.2% |
View BRIDGER MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Surrozen, Inc./DESold out | February 14, 2022 | 0 | 0.0% |
| Atara Biotherapeutics, Inc. | February 16, 2021 | 1,524,760 | 1.8% |
| Dicerna Pharmaceuticals Inc | February 14, 2020 | 1,981,633 | 2.9% |
| TG THERAPEUTICS, INC. | February 14, 2020 | 1,907,492 | 1.9% |
| CHIMERIX INCSold out | February 14, 2017 | 0 | 0.0% |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold out | February 14, 2017 | 0 | 0.0% |
| SeaSpine Holdings CorpSold out | February 14, 2017 | 0 | 0.0% |
| Trovagene, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
| ARROWHEAD RESEARCH CORPSold out | February 16, 2016 | 0 | 0.0% |
| PENNYMAC FINANCIAL SERVICES, INC.Sold out | February 16, 2016 | 0 | 0.0% |
View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
View BRIDGER MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.